GleamWall
中文EN

OSRH OSR Health, Inc.

Surgical & Medical Instruments & Apparatus · OTC · SEC CIK 1840425 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-50.4%
TTM net income YoY32.8%
TTM EPS YoY68.1%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin24.3%
Operating margin-946.7%
Net margin-599.0%
FCF margin—
EBITDA margin-944.8%

Returns

ROE-10.2%
ROA-5.6%
ROIC (approx.)-12.9%
Asset turnover0.01x

Leverage & solvency

Liabilities / assets24.5%
Debt / equity0.00x
Current ratio0.15x
Interest coverage-34.95x

Cash quality & payout

Operating cash flow / net income0.48x
Accruals ratio-2.9%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q2*2026-06-302026Q1*2026-03-312025Q4*2025-12-312025Q32025-09-302025Q2*2025-06-302025Q1*2025-03-312024Q4*2024-12-31
Income statement
Revenue$524,793$315,669$484,057$381,269$627,747$1.14M$761,272$915,252
Cost of revenue$486,915$229,065$323,776$251,565$366,014$1.10M$592,586$755,232
Gross profit$37,878$86,605$160,281$129,704$261,734$32,782$168,686$160,021
R&D expense$102,309$94,627$113,150$176,566-$1,794$53,525$90,149$14,476
SG&A expense$3.10M$3.12M$3.83M$6.52M$4.07M$5.26M$3.09M$1.77M
Operating income-$3.06M-$3.03M-$3.67M-$6.39M-$3.80M-$5.23M-$2.92M$6.55M
Interest expense$9,186$12,703$31,224$409,002$43,866$36,930$16,399$18,282
Pretax income-$2.37M-$1.44M-$3.92M-$7.78M-$4.49M-$5.23M-$11.39M$7.99M
Income tax-$464,737-$439,503-$452,314-$534,868-$1.29M——-$450,585
Net income-$1.61M-$848,905-$2.93M-$4.82M-$2.13M$331,414-$11.39M-$2.02M
EBITDA-$3.05M-$3.02M-$3.66M-$6.38M-$3.80M-$5.23M-$2.92M$6.51M
EPS (basic)-0.05-0.02-0.09—-0.100.02-1.04—
EPS (diluted)——-0.08———-1.04—
Weighted avg. shares (diluted)——34.27M———10.91M—
Balance sheet
Cash & equivalents$1.37M$1.50M$1.57M$1.70M$2.18M$1.58M$1.60M$341,543
Receivables$245,458$188,802$261,362$319,304$489,181$742,783$794,507$904,456
Inventory$396,910$594,287$462,455$196,432$185,095$198,827$736,630$922,107
Current assets$2.48M$2.87M$2.92M$2.82M$3.20M$2.88M$3.47M$2.33M
PP&E, net$152,000$142,284$153,508$169,130$98,109$3,667$999$2,334
Goodwill$33.12M$29.19M$29.73M$24.95M$25.53M$26.39M$24.41M$24.35M
Intangibles$149.62M$134.14M$138.97M$142.46M$148.15M$155.59M$146.16M$148.06M
Total assets$185.77M$166.62M$172.19M$171.24M$177.29M$185.42M$174.55M$175.24M
Current liabilities$16.68M$15.73M$17.90M$17.17M$15.03M$15.86M$13.88M$3.46M
Short-term debt$298,068$272,701$196,896$0$1.86M$630,603$245,482$1.80M
Long-term debt$197,501$271,349$272,914$0$0—$253,042$497,615
Total debt$495,569$544,050$469,810$0$1.86M—$498,524$2.30M
Total liabilities$45.56M$41.71M$44.80M$44.20M$43.13M$46.26M$42.27M$32.03M
Shareholders' equity$117.60M$104.27M$103.86M$77.64M$81.95M$83.70M$75.76M-$8.33M
Net debt-$872,743-$955,553-$1.10M-$1.70M-$317,412—-$1.10M$1.96M
Shares outstanding—35.12M33.30M26.60M23.67M19.81M19.28M2.15M
Cash flow statement
Operating cash flow-$370,518-$2.42M-$1.00M-$1.07M-$2.71M-$482,609-$64,069-$181,030
Capital expenditure————$94,190———
Free cash flow————-$2.81M———
Investing cash flow-$187,530-$88,325$11,677-$2.57M-$726,632-$528,424$1.19M-$187,812
Financing cash flow$247,105$2.47M$942,102$3.21M$4.12M$891,482$149,381$321,516
Depreciation & amortization$9,031$9,608$7,899$6,375$313$203$378-$41,949
Share buybacks———————$19.19M

Free plan shows the latest 8 periods; Pro shows all 19 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.